share_log

Chairman & CEO Wai Kuen Cheung Sold A Bunch Of Shares In Aidigong Maternal & Child Health

Chairman & CEO Wai Kuen Cheung Sold A Bunch Of Shares In Aidigong Maternal & Child Health

董事长兼首席执行官张伟权出售了爱帝宫母婴健康的大量股份
Simply Wall St ·  01/30 17:36

Some Aidigong Maternal & Child Health Limited (HKG:286) shareholders may be a little concerned to see that the Chairman & CEO, Wai Kuen Cheung, recently sold a substantial HK$8.4m worth of stock at a price of HK$0.052 per share. That's a big disposal, and it decreased their holding size by 30%, which is notable but not too bad.

一些爱迪宫母婴健康有限公司(HKG: 286)股东可能会有些担心,董事长兼首席执行官张伟权最近以每股0.052港元的价格出售了价值840万港元的大量股票。这是一笔巨额出售,它使他们的持股规模减少了30%,这值得注意,但还不错。

See our latest analysis for Aidigong Maternal & Child Health

查看我们对Aidigong母婴健康的最新分析

Aidigong Maternal & Child Health Insider Transactions Over The Last Year

Aidigong母婴健康去年内幕交易

The insider Kar Lung Lee made the biggest insider purchase in the last 12 months. That single transaction was for HK$50m worth of shares at a price of HK$0.25 each. So it's clear an insider wanted to buy, even at a higher price than the current share price (being HK$0.083). Their view may have changed since then, but at least it shows they felt optimistic at the time. In our view, the price an insider pays for shares is very important. As a general rule, we feel more positive about a stock if insiders have bought shares at above current prices, because that suggests they viewed the stock as good value, even at a higher price.

知情人李嘉隆进行了过去12个月中最大规模的内幕收购。该单笔交易以每股0.25港元的价格购买了价值5000万港元的股票。因此,很明显,即使价格高于当前股价(0.083港元),内部人士也想买入。从那以后,他们的观点可能发生了变化,但至少这表明他们当时感到乐观。我们认为,内部人士为股票支付的价格非常重要。通常,如果内部人士以高于当前价格的价格购买股票,我们对股票的看法会更加乐观,因为这表明他们认为股票物有所值,即使价格更高。

Happily, we note that in the last year insiders paid HK$59m for 230.01m shares. But they sold 275.39m shares for HK$20m. In total, Aidigong Maternal & Child Health insiders bought more than they sold over the last year. You can see a visual depiction of insider transactions (by companies and individuals) over the last 12 months, below. If you want to know exactly who sold, for how much, and when, simply click on the graph below!

令人高兴的是,我们注意到,去年内部人士支付了5900万港元购买了2.301亿股股票。但他们以2000万港元的价格出售了2.7539亿股股票。总的来说,Aidigong母婴健康内部人士的购买量超过了去年的卖出量。你可以在下面看到过去 12 个月的内幕交易(公司和个人)的直观描述。如果你想确切地知道谁卖了、卖了多少以及何时出售,只需点击下图!

insider-trading-volume
SEHK:286 Insider Trading Volume January 30th 2024
SEHK: 286 内幕交易量 2024 年 1 月 30 日

There are always plenty of stocks that insiders are buying. So if that suits your style you could check each stock one by one or you could take a look at this free list of companies. (Hint: insiders have been buying them).

内部人士总是会买入很多股票。因此,如果这适合你的风格,你可以逐一查看每只股票,也可以看看这份免费的公司名单。(提示:业内人士一直在购买它们)。

Insider Ownership Of Aidigong Maternal & Child Health

爱迪宫母婴健康的内部所有权

Many investors like to check how much of a company is owned by insiders. I reckon it's a good sign if insiders own a significant number of shares in the company. Aidigong Maternal & Child Health insiders own about HK$149m worth of shares (which is 41% of the company). This kind of significant ownership by insiders does generally increase the chance that the company is run in the interest of all shareholders.

许多投资者喜欢查看公司内部人士拥有多少股份。我认为,如果内部人士拥有该公司的大量股份,这是一个好兆头。Aidigong母婴健康内部人士拥有价值约1.49亿港元的股份(占该公司41%的股份)。内部人士的这种重要所有权通常会增加公司为所有股东的利益而经营的机会。

So What Do The Aidigong Maternal & Child Health Insider Transactions Indicate?

那么,爱迪宫母婴健康内幕交易表明了什么?

Unfortunately, there has been more insider selling of Aidigong Maternal & Child Health stock, than buying, in the last three months. On the other hand, the insider transactions over the last year are encouraging. We are also comforted by the high levels of insider ownership. So the recent selling doesn't worry us. So while it's helpful to know what insiders are doing in terms of buying or selling, it's also helpful to know the risks that a particular company is facing. At Simply Wall St, we've found that Aidigong Maternal & Child Health has 3 warning signs (1 doesn't sit too well with us!) that deserve your attention before going any further with your analysis.

不幸的是,在过去的三个月中,Aidigong母婴健康股票的内幕抛售多于买入的次数。另一方面,去年的内幕交易令人鼓舞。高水平的内部所有权也令我们感到欣慰。因此,最近的抛售并不让我们担心。因此,虽然了解内部人士在买入或卖出方面的所作所为很有帮助,但了解特定公司面临的风险也很有帮助。在 Simply Wall St,我们发现 Aidigong 母婴健康有 3 个警告信号(1 个对我们来说不太合适!)在进行进一步分析之前,这值得你注意。

Of course Aidigong Maternal & Child Health may not be the best stock to buy. So you may wish to see this free collection of high quality companies.

当然,Aidigong母婴健康可能不是最好的买入股票。因此,您可能希望看到这个免费的高质量公司集合。

For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions of direct interests only, but not derivative transactions or indirect interests.

就本文而言,内部人士是指向相关监管机构报告其交易的个人。我们目前只考虑公开市场交易和私下处置的直接利益,不包括衍生品交易或间接权益。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

对这篇文章有反馈吗?对内容感到担忧?直接联系我们。 或者,给编辑团队 (at) simplywallst.com 发送电子邮件。
Simply Wall St的这篇文章本质上是笼统的。我们仅使用公正的方法根据历史数据和分析师的预测提供评论,我们的文章无意作为财务建议。它不构成买入或卖出任何股票的建议,也没有考虑到您的目标或财务状况。我们的目标是为您提供由基本数据驱动的长期重点分析。请注意,我们的分析可能不考虑最新的价格敏感型公司公告或定性材料。简而言之,华尔街没有持有任何上述股票的头寸。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发